Some variants of the APOC3 gene, which encodes apolipoprotein C3, a constituent of the triglyceride-rich lipoproteins such as very low-density lipoproteins (VLDL) are associated with increased risk of MetS (34). This evidence concerns the gene APOC3 and metabolic syndrome.